ACTIVE

ESCAPHARM

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

119,4 k €

+13.6% YoY

Gross margin

233,5 k €

+19.4% YoY

Equity

821,2 k €

+14.8% YoY

Workforce

0,0 ETP

What does ESCAPHARM do?

ESCAPHARM is a Private company with limited liability incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Kluisbergen.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0897.206.151

Incorporation

08/04/2008

Legal form

Private company with limited liability

Registered office

Dalstraat 1
9690 Kluisbergen · FlandreSee on map

Contributed capital

20 000,00 €

Latest accounts

31/12/2025

Average workforce

0,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Gross margin	233,5 k €	+19.4%	195,6 k €	-1.8%	199,2 k €	+20.5%	165,3 k €	-9.2%	182,1 k €	+15.5%	157,7 k €	+78.2%	88,5 k €	+5.7%	83,7 k €	-17.3%	101,2 k €	-5.5%	107,1 k €	-5.1%	112,8 k €	+5.8%	106,6 k €	-1.2%	107,9 k €	+0.6%	107,3 k €	+9.0%	98,5 k €	+2.8%	95,8 k €	+76.6%	54,2 k €
EBITDA	225,6 k €	+15.6%	195,2 k €	-1.7%	198,6 k €	+20.6%	164,7 k €	-9.2%	181,5 k €	+15.6%	156,9 k €	+78.9%	87,7 k €	+5.7%	83 k €	-17.6%	100,7 k €	-5.5%	106,6 k €	-4.7%	111,8 k €	+5.4%	106,1 k €	-1.2%	107,4 k €	+0.7%	106,6 k €	+8.9%	97,9 k €	+2.9%	95,2 k €	+78.2%	53,4 k €
Operating result	207,7 k €	+12.6%	184,4 k €	-2.2%	188,6 k €	+21.9%	154,7 k €	-9.4%	170,7 k €	+11.1%	153,6 k €	+96.4%	78,2 k €	+6.5%	73,4 k €	-19.4%	91,1 k €	-9.2%	100,4 k €	-4.9%	105,6 k €	-0.5%	106,1 k €	+0.3%	105,8 k €	+5.6%	100,2 k €	+9.6%	91,4 k €	+3.1%	88,7 k €	+111%	42,1 k €
Net result	119,4 k €	+13.6%	105,1 k €	-1.3%	106,4 k €	+30.9%	81,3 k €	-8.8%	89,1 k €	+19.7%	74,4 k €	+388%	15,2 k €	+25.3%	12,2 k €	-36.2%	19,1 k €	-35.8%	29,7 k €	-18.8%	36,5 k €	+2.8%	35,5 k €	+4.1%	34,1 k €	+15.5%	29,5 k €	+14.7%	25,8 k €	+18.8%	21,7 k €	+13.4%	19,1 k €
Balance sheet
Equity	821,2 k €	+14.8%	715,4 k €	+17.2%	610,3 k €	+13.7%	536,8 k €	+17.4%	457,1 k €	+23.7%	369,6 k €	+24.5%	296,8 k €	+4.8%	283,2 k €	+4.5%	271 k €	+7.6%	252 k €	+13.3%	222,3 k €	+19.7%	185,8 k €	+23.7%	150,2 k €	+29.4%	116,1 k €	+34.1%	86,5 k €	+42.4%	60,8 k €	+55.4%	39,1 k €
Total assets	1,5 M €	+11.2%	1,3 M €	+15.5%	1,1 M €	-0.7%	1,1 M €	-0.9%	1,2 M €	+6.9%	1,1 M €	+0.1%	1,1 M €	-0.2%	1,1 M €	-3.4%	1,1 M €	+0.6%	1,1 M €	+2.0%	1,1 M €	+3.3%	1,1 M €	-3.6%	1,1 M €	+1.2%	1,1 M €	+0.1%	1,1 M €	-0.6%	1,1 M €	-0.0%	1,1 M €
Cash	32,8 k €	+0.2%	32,8 k €	-9.8%	36,3 k €	-42.5%	63,2 k €	-6.5%	67,6 k €	+111%	32,1 k €	+25.8%	25,5 k €	+111%	12,1 k €	-34.1%	18,3 k €	+71.6%	10,7 k €	-53.3%	22,9 k €	+82.7%	12,5 k €	-75.3%	50,6 k €	+40.4%	36,1 k €	+38.4%	26,1 k €	-5.1%	27,5 k €	+19.5%	23 k €
Debts	634,5 k €	+12.5%	563,8 k €	+14.5%	492,6 k €	-14.3%	574,7 k €	-13.8%	666,9 k €	-2.4%	683 k €	-10.0%	759 k €	-2.6%	779,5 k €	-6.7%	835,7 k €	-2.2%	854,4 k €	-0.9%	862 k €	-0.1%	862,8 k €	-7.4%	931,9 k €	-2.2%	952,8 k €	-3.6%	988 k €	-3.2%	1 M €	-2.0%	1 M €
Other
Workforce	0,0 ETP		0,0 ETP		0,0 ETP		0,0 ETP		–		–		–		–		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

Renaud Mertens

Manager

Active

SOPHIE GLORIEUX

Manager

Active

Ended mandates

Renaud Mertens

Director · since 08 avril 2008

Ended

Sophie Glorieux

Director · since 08 avril 2008

Ended

Sophie Glorieux

Manager · since 08 avril 2008

Ended

SOPHIE GLORIEUX

Manager · until 30 septembre 2014

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	13/08/2026	22/08/2025	22/08/2024	24/08/2023	25/08/2022	28/06/2021
General meeting	03/08/2026	20/06/2025	20/06/2024	20/06/2023	20/06/2022	21/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

17 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	03/08/2026	13/08/2026	Dutch	PDF
Abridged model	31/12/2024	20/06/2025	22/08/2025	Dutch	PDF
Abridged model	31/12/2023	20/06/2024	22/08/2024	Dutch	PDF
Abridged model	31/12/2022	20/06/2023	24/08/2023	Dutch	PDF
Abridged model	31/12/2021	20/06/2022	25/08/2022	Dutch	PDF
Abridged model	31/12/2020	21/06/2021	28/06/2021	Dutch	PDF
Abridged model	31/12/2019	20/06/2020	24/08/2020	Dutch	PDF
Abridged model	31/12/2018	20/06/2019	27/06/2019	Dutch	PDF
Abridged model	31/12/2017	20/06/2018	02/07/2018	Dutch	PDF
Abridged model	31/12/2016	20/06/2017	16/08/2017	Dutch	PDF
Abridged model	31/12/2015	20/06/2016	28/06/2016	Dutch	PDF
Abridged model	31/12/2014	20/06/2015	22/06/2015	Dutch	PDF
Abridged model	31/12/2013	20/06/2014	03/07/2014	Dutch	PDF
Abridged model	31/12/2012	20/06/2013	27/06/2013	Dutch	PDF
Abridged model	31/12/2011	20/06/2012	25/07/2012	Dutch	PDF
Abridged model	31/12/2010	20/06/2011	29/06/2011	Dutch	PDF
Abridged model	31/12/2009	21/06/2010	27/07/2010	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

Renaud Mertens

Manager

Active

SOPHIE GLORIEUX

Manager

Active

Ended mandates

Renaud Mertens

Director · since 08 avril 2008

Ended

Sophie Glorieux

Director · since 08 avril 2008

Ended

Sophie Glorieux

Manager · since 08 avril 2008

Ended

SOPHIE GLORIEUX

Manager · until 30 septembre 2014

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office05/04/2019
MAATSCHAPPELIJKE ZETEL
PDF
Other19/02/2015
DIVERSEN
PDF
Registered office14/12/2009
MAATSCHAPPELIJKE ZETEL
PDF
Other23/04/2008
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025119,4 k €↑
2024
Annual accounts 2024105,1 k €↓
2023
Annual accounts 2023106,4 k €↑
2022
Annual accounts 202281,3 k €↓
2021
Annual accounts 202189,1 k €↑
2020
Annual accounts 202074,4 k €↑
2019
Annual accounts 201915,2 k €↑
2018
Annual accounts 201812,2 k €↓
2017
Annual accounts 201719,1 k €↓
2016
Annual accounts 201629,7 k €↓
2015
Annual accounts 201536,5 k €↑
2014
Annual accounts 201435,5 k €↑
2013
Annual accounts 201334,1 k €↑
2012
Annual accounts 201229,5 k €↑
2011
Annual accounts 201125,8 k €↑
2010
Annual accounts 201021,7 k €↑
2009
Annual accounts 200919,1 k €
08/04/2008
IncorporationPrivate company with limited liability

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ESCAPHARM

Overview

What does ESCAPHARM do?

Trend over 17 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline